ECSP992874A - HETERO-CYCLIC COMPOUNDS AS ROTHAMASE ENZYME INHIBITORS - Google Patents
HETERO-CYCLIC COMPOUNDS AS ROTHAMASE ENZYME INHIBITORSInfo
- Publication number
- ECSP992874A ECSP992874A ECSP992874A ECSP992874A EC SP992874 A ECSP992874 A EC SP992874A EC SP992874 A ECSP992874 A EC SP992874A EC SP992874 A ECSP992874 A EC SP992874A
- Authority
- EC
- Ecuador
- Prior art keywords
- enzyme inhibitors
- rothamase
- hetero
- cyclic compounds
- compounds
- Prior art date
Links
- 239000002532 enzyme inhibitor Substances 0.000 title abstract 2
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000028389 Nerve injury Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 abstract 1
- 102100020739 Peptidyl-prolyl cis-trans isomerase FKBP4 Human genes 0.000 abstract 1
- 101710147152 Peptidyl-prolyl cis-trans isomerase FKBP4 Proteins 0.000 abstract 1
- 108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 abstract 1
- 230000008764 nerve damage Effects 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 230000009689 neuronal regeneration Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Los compuestos de la fórmula: (gráfico), en la que R1, Y, W, A y R2 son como se han definido anteriormente, son inhibidores de enzimas rotamas, en particular, FKBP-12 y FKBP-52. Por lo tanto, los compuestos moderan la regeneración y extensión neuronal y pueden usarse para el tratamiento de trastornos neurológicos producidos por enfermedades neurodegenerativas y lesiones nerviosas.Compounds of the formula: (graph), where R1, Y, W, A and R2 are as defined above, are rotama enzyme inhibitors, in particular FKBP-12 and FKBP-52. Therefore, the compounds moderate neuronal regeneration and extension and can be used for the treatment of neurological disorders caused by neurodegenerative diseases and nerve injuries.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992874 ECSP992874A (en) | 1999-03-01 | 1999-03-01 | HETERO-CYCLIC COMPOUNDS AS ROTHAMASE ENZYME INHIBITORS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992874 ECSP992874A (en) | 1999-03-01 | 1999-03-01 | HETERO-CYCLIC COMPOUNDS AS ROTHAMASE ENZYME INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP992874A true ECSP992874A (en) | 1999-06-11 |
Family
ID=42043862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP992874 ECSP992874A (en) | 1999-03-01 | 1999-03-01 | HETERO-CYCLIC COMPOUNDS AS ROTHAMASE ENZYME INHIBITORS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP992874A (en) |
-
1999
- 1999-03-01 EC ECSP992874 patent/ECSP992874A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8468501A1 (en) | HETERO-CYCLIC COMPOUNDS AS ROTHAMASE ENZYME INHIBITORS | |
| PA8478501A1 (en) | HETERO-CYCLE COMPOUNDS AS ROTAMASE ENZYME INHIBITORS | |
| ES2127946T3 (en) | DIAZABYCLIC NEUROCININE ANTAGONISTS. | |
| CR6577A (en) | TRICYCLE POLY INHIBITORS (ADP-RIBOSA) POLYMERASES | |
| GT200100151A (en) | DERIVATIVES OF 3-INDOLIL-4-FENIL-1H-PIRROL-2,5-DIONE AS INHIBITORS OF GLUCOGENO SINTASA QUINASA-3B. | |
| MA27933A1 (en) | INHIBITORS OF AKT ACTIVITY | |
| ECSP055719A (en) | TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| PE20020521A1 (en) | SUBSTITUTE HETEROCYCLIC COMPOUNDS TO TREAT MULTIPLE DRUG RESISTANCE | |
| UY28150A1 (en) | THERAPEUTIC AGENTS | |
| BRPI0413582A (en) | compounds, compositions and methods for inhibiting proteasome activity | |
| BRPI0414544A (en) | 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders | |
| DE69833451D1 (en) | TREATMENT OF SCHIZOPHRENIA WITH AMPAKINS AND NEUROLEPTIKA | |
| UY28144A1 (en) | THERAPEUTIC AGENTS | |
| ATE439140T1 (en) | AMYLIN AND AMYLIN AGONISTS FOR THE TREATMENT OF PSYCHIATRIC DISEASES AND DISORDERS | |
| BR0308937A (en) | Fused imidazo compounds | |
| ECSP045139A (en) | ACETYLENE DERIVATIVES THAT HAVE ANTAGONISTIC ACTIVITY OF MGluR5 | |
| PT751939E (en) | NAFTILAMIDES AS AGENTS FOR THE CENTRAL NERVOUS SYSTEM | |
| SV2003001173A (en) | 1-RENT OR 1-CICLOALQUIL-TRIAZOLO [4,3-A] QUINAZOLIN-5- WAVES AS PHOSPHODIESTERASE INHIBITORS | |
| ECSP034796A (en) | DIHIDRO-BENZO DERIVATIVES [b] [1,4] DIAZEPIN-2-ONA ANTAGONISTS I MGLUR2 | |
| ES2162257T3 (en) | N-AMINOALQUILDIBENZOFURANCARBOXAMIDAS AS SPECIFIC LINKS OF THE DOPAMINE RECEPTOR SUBTIPE. | |
| MX2009006885A (en) | Pyrrolo [3, 2-a] pyridine derivatives for inhibiting ksp kinesin activity. | |
| MX9606494A (en) | ORGANIC COMPOUNDS. | |
| DK1438034T3 (en) | Use of -phenyl-3-dimethylaminiopropane compounds in the treatment of urinary incontinence | |
| BRPI0519267A2 (en) | quinoline derivative, its use, production and medicine containing the same | |
| NO20052153L (en) | Piperazine and piperidine derivatives for the treatment of neurological diseases. |